genOway Société anonyme (EPA:ALGEN)
France · Delayed Price · Currency is EUR 2.200
-0.020 (-0.90%)
Oct 22, 2026, 5:35 PM CEST
genOway Société anonyme Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 19.77 | 20.96 | 22.06 | 20.05 | 17.05 | 14.02 |
Other Revenue | 4.8 | 5.07 | 3.78 | 5.39 | 2.89 | 4 |
| 24.58 | 26.03 | 25.84 | 25.44 | 19.94 | 18.02 | |
Revenue Growth | -2.21% | 0.72% | 1.59% | 27.56% | 10.66% | 10.46% |
Cost of Revenue | 14.08 | 13.27 | 12.81 | 10.67 | 9.3 | 9.39 |
Gross Profit | 10.5 | 12.76 | 13.04 | 14.76 | 10.64 | 8.63 |
Selling, General & Admin | 11.03 | 10.37 | 10.24 | 9.2 | 8.04 | 8.22 |
Other Operating Expenses | -2.77 | -2.29 | -1.52 | -1.25 | -0.54 | -0.82 |
Operating Expenses | 11.89 | 11.49 | 11.7 | 12.35 | 10.01 | 9.33 |
Operating Income | -1.39 | 1.27 | 1.34 | 2.41 | 0.63 | -0.7 |
Interest Expense | -0.38 | -0.31 | -0.15 | - | -0.49 | -0.27 |
Interest & Investment Income | 0.02 | 0.03 | 0.26 | 0.04 | 0.17 | 0.25 |
Currency Exchange Gain (Loss) | 0.01 | 0.02 | 0.38 | - | - | - |
Other Non Operating Income (Expenses) | 0.01 | - | - | - | - | - |
EBT Excluding Unusual Items | -1.74 | 1.02 | 1.84 | 2.45 | 0.31 | -0.72 |
Gain (Loss) on Sale of Investments | 0.08 | 0.09 | 0.08 | - | - | - |
Gain (Loss) on Sale of Assets | -0.18 | -0.18 | -0.42 | -0.9 | - | - |
Other Unusual Items | -0.25 | - | 0.31 | 0 | 0.45 | 0.37 |
Pretax Income | -2.1 | 0.92 | 1.81 | 1.55 | 0.76 | -0.35 |
Income Tax Expense | -0 | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
Net Income | -2.1 | 0.93 | 1.83 | 1.57 | 0.78 | -0.32 |
Net Income to Common | -2.1 | 0.93 | 1.83 | 1.57 | 0.78 | -0.32 |
Net Income Growth | - | -49.32% | 16.79% | 101.55% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.17 | -9.78 | 4.75 | - | - | - |
Gross Margin | 42.73% | 49.02% | 50.45% | 58.04% | 53.37% | 47.90% |
Operating Margin | -5.67% | 4.89% | 5.19% | 9.49% | 3.16% | -3.87% |
Profit Margin | -8.53% | 3.56% | 7.08% | 6.16% | 3.90% | -1.79% |
Free Cash Flow Margin | -8.82% | -37.56% | 18.39% | - | - | - |
EBITDA | 2.08 | 4.43 | 4.31 | 6.81 | 3.15 | 0.52 |
EBITDA Margin | 8.46% | 17.01% | 16.68% | 26.77% | 15.79% | 2.90% |
D&A For EBITDA | 3.47 | 3.15 | 2.97 | 4.4 | 2.52 | 1.22 |
EBIT | -1.39 | 1.27 | 1.34 | 2.41 | 0.63 | -0.7 |
EBIT Margin | -5.67% | 4.89% | 5.19% | 9.49% | 3.16% | -3.87% |
Revenue as Reported | 27.98 | 28.56 | 27.66 | 26.59 | 21.4 | 19.8 |